Decorative petal
Banner image
Banner image mobile

Investors

We maintain a strong presence in key markets with a sharp focus on long-term, sustainable growth. Transparency and accountability through comprehensive reporting and disclosures remains a top priority for us. Our corporate governance framework and policies are designed to protect and enhance shareholder value while reinforcing trust and integrity.

What's New

February 4, 2026
Press
Release

Lupin Launches Topiramate
Extended-Release Capsules in
the United
States

February 2, 2026
Press
Release

Lupin and TB Alliance Join
Forces to Advance Telacebec for
the Treatment of Tuberculosis and
Other Mycobacterial

February 2, 2026
Press
Release

Lupin Launches
Dasatinib Tablets
in the
United

January 23, 2026
Press
Release

Lupin Receives Highest ESG
Rating from CDP for
Climate Change and Water
Security

Reports and Filings

Corporate Governance
Loading chart data…

News and Events

Press Release

Lupin Q2 FY2026 Results

Annual General Meeting

The 42nd Annual General Meeting was held on Thursday, August 2, 2024.

Earnings Calls

Presentations

Investor Calendar

Office meeting room

Subscribe forInvestor updates

Product Finder
Investors | Reports and Filings, News and Events - Lupin